$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Monoglyceride/lactate ester permeation enhancer for oxybutnin 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-013/02
출원번호 US-0070492 (1998-04-30)
발명자 / 주소
  • Lee Eun Soo
  • Watanabe Tyler
  • Gale Robert M.
  • Burkoth Terry L.
출원인 / 주소
  • ALZA Corporation
대리인 / 주소
    Rafa
인용정보 피인용 횟수 : 26  인용 특허 : 94

초록

A composition of matter for application to a body surface or membrane to administer oxybutynin by permeation through the body surface or membrane, the composition comprising, in combination, the oxybutynin to be administered, in a therapeutically effective amount; and a permeation-enhancing mixture

대표청구항

[ What is claimed is:] [1.] A method for the treatment of neurogenic bladder disorders comprising:a) administering oxybutinin at a therapeutically effective rate to an area of skin;b) simultaneously administering a permeation enhancer to the area of skin which is sufficient to substantially increase

이 특허에 인용된 특허 (94)

  1. Hester ; Jr. Jackson B. (Kalamazoo MI), 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines.
  2. Sandbank Barry M. (Herts GBX), Adhesive coated dressing and applicators therefor.
  3. Resch James F. (Newark DE), Antagonizing the pharmacological effects of a benzodiazepine receptor agonist.
  4. Luedders Wilmer L. (Cincinnati OH), Anti-acne composition.
  5. Thompson Edward D. (Cincinnati OH) Carter Stephen B. (Cincinnati OH) Manring Gary L. (Oxford OH), Anti-acne composition.
  6. Urquhart John (Palo Alto CA) Chandrasekaran Santosh Kumar (Palo Alto CA) Shaw Jane Elizabeth (Atherton CA), Bandage for transdermally administering scopolamine to prevent nausea.
  7. Meguro ; Kanji ; Kuwada ; Yutaka, Benzodiazepine derivatives.
  8. Sablotsky Steven (Miami FL) Gentile Cheryl M. (Plantation FL), Breathable backing.
  9. Voith Katherine (Dorval CAX), Combination of b 상세보기
  • Hagerman Edward M. (Royal Oak MI) Mitchell Harry A. (Sterling Heights MI), Compacted sheet molding compound.
  • Rajadhyaksha Vithal J. (27436 Esquina Mission Viejo CA 92691), Compositions and method comprising heterocyclic compounds containing two heteroatoms as membrane penetration enhancers.
  • Spicer Darcy V. (Pasadena CA) Pike Malcolm C. (Long Beach CA), Contraceptive methods and formulations for use therein.
  • Zentner Gaylen M. (Lawrence KS) Rork Gerald S. (Lawrence KS) Himmelstein Kenneth J. (Irvine CA), Controlled porosity osmotic pump.
  • Lee Eun Soo (Redwood City CA) Theeuwes Felix (Los Altos Hills CA) Wong Patrick S. L. (Hayward CA) Yum Su Il (Los Altos CA) Zaffaroni Alejandro (Atherton CA), Delayed onset transdermal delivery device.
  • Benefiel Robert L. (Greenfield IN) Clarke John W. (Indianapolis IN) Harris Dale C. (Fairland IN) Morff Robert J. (Indianapolis IN) Oren Peter L. (Fishers IN), Delivery device for orally administered therapeutic agents.
  • Smith ; Donald E., Dermatological compositions.
  • Smith ; Donald E., Dermatological compositions.
  • Smith Donald Edward (Hamilton OH), Dermatological compositions.
  • Smith Donald Edward (Hamilton OH), Dermatological compositions.
  • Higuchi Takeru (Lawrence KS) Hussain Anwar (Lexington KY), Device consisting of copolymer having acetoxy groups for delivering drugs.
  • Chang Yunik (Toms River NJ) Patel Dinesh C. (Murray UT) Ebert Charles D. (Salt Lake City UT), Device for administering an active agent to the skin or mucosa.
  • Zentner Gaylen M. (Lawrence KS), Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins.
  • Zentner Gaylen M. (Lawrence KS), Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins.
  • Chandrasekaran Santosh K. (Palo Alto CA), Dissolution controlled active agent dispenser.
  • Campbell, Patricia S.; Chandrasekaran, Santosh K., Dosage for coadministering drug and percutaneous absorption enhancer.
  • Berry Peter W. (Herts GBX) Holden Paul (Herts GBX), Drug delivery device, its preparation and use.
  • Leeper Harold M. (Mountain View CA), Elastomeric active agent delivery system and method of use.
  • Austin Gerald W. (Salem VA), External single-use catheter.
  • Casper Robert F. (Toronto CAX), Hormone preparation and method.
  • Casper Robert F. (Toronto CAX), Hormone preparation and method.
  • Casper Robert F. (Toronto CAX), Hormone preparation and method.
  • Enscore, David J.; Gale, Robert M., Matrix composition for transdermal therapeutic system.
  • Tsuk Andrew G. (Arlington MA), Menthol enhancement of transdermal drug delivery.
  • Saito Kenichiro (Menlo Park CA) Heller Jorge (Menlo Park CA) Skinner Wilfred (Menlo Park CA), Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent.
  • Kurtz Neil M. (Westport CT) Newton Roger E. (Evansville IN) Temple ; Jr. Davis L. (Wallingford CT), Method for alleviation of panic disorders.
  • Gale Robert M. (Mountain View CA), Method for increasing oxygen supply by administering vasodilator.
  • Heller Jorge (Woodside CA) Skinner Wilfred A. (Portola Valey CA) Saito Kenichiro (Menlo Park CA) Satoh Susumu (Osaka JPX), Method for percutaneously administering physiologically active agents.
  • Saito Kenichiro (Menlo Park CA) Heller Jorge (Woodside CA) Skinner Wilfred A. (Portola Valley CA), Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent.
  • Hussain Anwar A. (Lexington KY), Method of administering narcotic antagonists and analgesics and novel dosage forms containing same.
  • Glassman Alexander H. (Teaneck NJ), Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking.
  • Glassman Alexander H. (Teaneck NJ), Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking.
  • Glassman Alexander H. (Teaneck NJ), Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking.
  • Bennett Debra A. (Middlesex NJ), Method of suppressing benzodiazepine induced sedation with 2-(p-methoxypenyl)-pyrazolo[4,3-c]quinolin-3(5H)-one or a sal.
  • Granger Colin D. (Chester NJ) Simon Thomas H. (Morris Plains NJ), Misuse-resistive transdermal opioid dosage form.
  • Zentner Gaylen M. (Lawrence KS) Himmelstein Kenneth J. (Irvine CA) Rork Gerald S. (Lawrence KS), Multiparticulate controlled porosity osmotic.
  • Seth Pyare (Krebsenbachweg 8 Aesch 4147 CHX) Seth Pawan (11 Guru Sarday Road Calcutta 700019 INX), Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical ex.
  • Gallager Dorothy W. (Guilford CT), Novel use of benzodiazepine antagonist.
  • Cooper, Eugene R., Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one.
  • Cooper, Eugene R., Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone.
  • Cooper, Eugene R.; Loomans, Maurice E.; Fawzi, Mahdi B., Penetrating topical pharmaceutical compositions containing corticosteroids.
  • Mahjour Majid (Morris Plains NJ) Iyer Uma (Mendham NJ) Fawzi Mahdi B. (Flanders NJ), Penetration enhancement system.
  • Patel Dinesh C. (Murray UT) Chang Yunik (Lakewood NJ), Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols.
  • Rajadhyaksha Vithal J. (Mission Viejo CA), Penetration enhancers for transdermal drug delivery of systemic agents.
  • Azuma Masato (Osaka JPX) Negama Tsutomu (Osaka JPX) Yoshida Mitsuhiro (Saitama JPX) Fujimori Hiroyuki (Saitama JPX), Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation.
  • Burghart Walter (A-1030 Vienna ; Salmgasse 4 Vienna ATX) Burghart Kurt (D-2217 Rosdorf ; Saegeberg 8 Rosdorf DEX), Pharmaceutical preparation and methods for its production.
  • Yoshida Mitsuhiro (Saitama JPX) Fujimori Hiroyuki (Saitama JPX) Asakawa Hidenori (Saitama JPX) Kasai Masayoshi (Gifu JPX) Kayano Masanori (Saitama JPX) Osawa Shigemitsu (Saitama JPX), Pharmaceutical preparation for percutaneous administration containing bunazosin or its salt.
  • Yoshida Mitsuhiro (Fukaya JPX) Morita Yutaka (Honjou JPX) Ishino Yoshio (Kumagaya JPX) Ohsawa Shigemitsu (Honjou JPX), Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof.
  • Sipos, Tibor, Potentiated medicaments.
  • Yoshida Mitsuhiro (Saitama JPX) Fujimori Hiroyuki (Saitama JPX) Ishino Yoshio (Saitama JPX) Sasaki Akira (Tokyo JPX) Kasai Masayoshi (Gifu JPX) Ohmori Keiji (Gunma JPX) Konita Noriko (Saitama JPX) Yu, Preparation for endermism containing dopamine derivatives.
  • Huber Joel E. (Kalamazoo MI), Process to prepare a 상세보기
  • Baker Richard W. (Palo Alto CA) Kochinke Frank (Fremont CA) Huang Carl (Palo Alto CA), Prolonged activity nicotine patch.
  • Leeper Harold M. (Mountain View CA) Nedberge Diane (Los Altos CA) Taskovich Lina T. (Palo Alto CA), Skin permeation enhancer compositions.
  • Cheng Yu-Ling (Cupertino CA) Nedberge Diane E. (Los Altos CA) Sugihara Edna (Mountain View CA), Skin permeation enhancer compositions using glycerol monolaurate.
  • Taskovich Lina T. (Palo Alto CA), Skin permeation enhancer compositions using glycerol monooleate.
  • Cheng Yu-Ling (Cupertino CA) Gale Robert M. (Los Altos CA) Sugihara Edna (Mountain View CA) Sanders Harold F. (San Jose CA), Skin permeation enhancer compositions using sucrose esters.
  • Cheng Yu-Ling (Cupertino CA) Gale Robert M. (Los Altos CA) Sugihara Edna (Mountain View CA) Sanders Harold F. (San Jose CA), Skin permeation enhancer compositions using sucrose esters.
  • Heiber Sonia (Salt Lake City UT) Patel Dinesh (Murray UT) Ebert Charles D. (Salt Lake City UT), Sorbitan esters as skin permeation enhancers.
  • Osborne James L. (Mountain View CA) Nelson Melinda (Sunnyvale CA) Enscore David J. (Saratoga CA) Yum Su I. (Los Altos CA) Gale Robert M. (Los Altos CA), Subsaturated nicotine transdermal therapeutic system.
  • Enscore David J. (Sunnyvale CA) Campbell Patricia S. (Palo Alto CA) Osborne James L. (Mountain View CA) Smart Melinda K. (Sunnyvale CA) Yum Su I. (Los Altos CA), Subsaturated transdermal therapeutic system having improved release characteristics.
  • Hidaka Osafumi (Tokyo JPX) Sakai Tomoki (Tokyo JPX) Sakano Toyoaki (Tokyo JPX), Sustained release pharmaceutical plaster.
  • Chandrasekaran Santosh K. (Palo Alto CA) Darda Siegfried (Ingelheim am Rhein CA DEX) Michaels Alan S. (Atherton CA) Cleary Gary W. (Palo Alto CA), Therapeutic system for administering clonidine transdermally.
  • Chandrasekaran Santosh K. (Palo Alto CA), Therapeutic system for administering drugs to the skin.
  • Fawzi Mahdi B. (Fairfield OH), Topical antimicrobial anti-inflammatory compositions.
  • Aungst Bruce (Wilmington DE) DiLuccio Robert C. (Wilmington DE), Trandermal delivery of opioids.
  • Chien Yie W. (North Brunswick NJ) Chiang Chin-Chih (Piscataway NJ) Tojo Kabuji (Highland Park NJ), Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration.
  • Gale Robert M. (Los Altos CA) Goetz Victor (Palo Alto CA) Lee Eun S. (Redwood City CA) Taskovich Lina T. (Palo Alto CA) Yum Su I. (Los Altos CA), Transdermal administration of fentanyl and device therefor.
  • Lee Eun S. (Redwood City CA) Nedberge Diane E. (Los Altos CA) Yum Su I. (Los Altos CA), Transdermal administration of oxybutynin.
  • Gale Robert M. (Los Altos CA) Enscore David J. (Sunnyvale CA) Nedberge Diane E. (Los Altos CA) Nelson Melinda (Sunnyvale CA) Cheng Yu-Ling (Cupertino CA) Libicki Shari B. (Palo Alto CA), Transdermal administration of progesterone, estradiol esters, and mixtures thereof.
  • Nedberge Diane E. (Los Altos CA) Campbell Patricia S. (Palo Alto CA) Gale Robert M. (Los Altos CA) Yum Su I. (Los Altos CA), Transdermal contraceptive formulations.
  • Gale Robert M. (Los Altos CA) Nedberge Diane E. (Los Altos CA) Atkinson Linda E. (Portola Valley CA), Transdermal contraceptive formulations, methods and devices.
  • Gale Robert M. (Los Altos CA) Enscore David J. (Sunnyvale CA), Transdermal delivery of highly ionized fat insoluble drugs.
  • Lawter James R. (Orange NY) Pawelchak John M. (Park Ridge NJ), Transdermal delivery of pharmaceuticals.
  • Sanders Harold F. (Palo Alto CA) Cheng Yu-Ling (Cupertino CA) Enscore David J. (Saratoga CA) Libicki Shari B. (Palo Alto CA), Transdermal drug composition with dual permeation enhancers.
  • Gale Robert M. (Los Altos CA) Nedberge Diane E. (Los Altos CA) Atkinson Linda E. (Portola Valley CA), Transdermal formulations, methods and devices.
  • Gale Robert M. (Los Altos) Nedberge Diane E. (Los Altos) Atkinson Linda E. (Portola Valley CA), Transdermal formulations, methods and devices.
  • Campbell Patricia S. (Palo Alto CA) Eckenhoff James B. (Los Altos CA), Transdermal therapeutic system having improved delivery characteristics.
  • Fankhauser Peter (Ettingen CHX) Schenkel Lotte (Basle CHX), Transdermal therapeutic systems for active ingredient combinations.
  • Chen Yu-Ling (Cupertino CA) Chun Leslie L. (Palo Alto CA) Enscore David J. (Sunnyvale CA), Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine.
  • Lewis John W. (North Humberside GBX), Treating opiate dependence.
  • Golwyn Daniel H. (701 E. Semoran Blvd. Altamonte Springs FL 32715), Treatment of immunologically based disorders, specifically Crohn\s disease.
  • Mahan Donald R. (San Jose CA), Treatment of negative symptoms of schizophrenia.
  • Coleman James H. (Cumberland RI), Treatment of panic disorders with alprazolam.
  • Fawzi Mahdi B. (Flanders NJ) Iyer Uma R. (Mendham NJ) Mahjour Majid (Netcong NJ), Use of commercial lecithin as skin penetration enhancer.
  • Zupan Jacob A. (St. Joseph MO), Use of eucalyptol for enhancing skin permeation of bio-affecting agents.
  • 이 특허를 인용한 특허 (26)

    1. Carrara,Dario; Porto,Gabriel; Rodriguez,Jorge, Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels.
    2. Sanders, Steven W.; Ebert, Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
    3. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
    4. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
    5. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
    6. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
    7. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
    8. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
    9. Anu Mahashabde ; Martha Francine Kay ; Donald F. Koelmel, Device and method for treating urinary incontinence in females.
    10. Carrara,Dario Norberto R.; Grenier,Arnaud; Besse,Celine; Simes,Stephen M.; Lehman,Leah M., Formulations for transdermal or transmucosal application.
    11. Malcolm, Karl; Woolfson, David; Elliott, Grant; Shephard, Martin, Intravaginal drug delivery devices for the administration of an antimicrobial agent.
    12. Gyory J. Richard ; Haak Ronald P., Layered rate controlling membranes for use in an electrotransport device.
    13. Lehman, Leah M.; Simes, Stephen M., Method and apparatus for transdermal or transmucosal application of testosterone.
    14. Gochnour, Scott; Subramanyan, Venkatesh; Kimball, Michael W., Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions.
    15. Gochnour, Scott; Subramanyan, Venkatesh; Kimball, Michael W., Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions.
    16. Lehman, Leah M.; Simes, Stephen M., Methods and apparatus for transdermal or transmucosal application of testosterone.
    17. Simes, Stephen M.; Lehman, Leah M., Methods of treating hot flashes with formulations for transdermal or transmucosal application.
    18. Simes, Stephen M.; Lehman, Leah M., Methods of treating hot flashes with formulations for transdermal or transmucosal application.
    19. Kimball, Michael W., Peelable pouch for transdermal patch and method for packaging.
    20. Kimball, Michael W., Peelable pouch for transdermal patch and method for packaging.
    21. Kimball, Michael W., Peelable pouch for transdermal patch and method for packaging.
    22. Grenier,Arnaud; Carrara,Dario Norberto R.; Besse,Celine, Permeation enhancing compositions for anticholinergic agents.
    23. Carrara, Dario Norberto R.; Grenier, Arnaud, Transdermal compositions for anticholinergic agents.
    24. Carrara, Dario Norberto R.; Grenier, Arnaud, Transdermal compositions for anticholinergic agents.
    25. Carrara, Dario Norberto R.; Grenier, Arnaud, Transdermal testosterone formulation for minimizing skin residues.
    26. Ebert, Charles D.; Sanders, Steven W., Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy.

    문의처: helpdesk@kisti.re.kr전화: 080-969-4114

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로